医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Frontier Health to Announce Fourth Quarter and Fiscal Year 2020 Financial Results on April 8, 2021

2021年03月31日 PM08:30
このエントリーをはてなブックマークに追加


 

BEIJING

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that it plans to release its fourth quarter and fiscal year ended December 31, 2020, financial results before the U.S. market opens on Thursday, April 8, 2021.

The Company will hold a conference call on Thursday, April 8, 2021, at 8:00 am Eastern Time (or Thursday, April 8, 2021, at 8:00 pm Beijing Time) to discuss the financial results. Participants may access the call by dialing the following numbers:

United States: 1-877-407-0789
International: 1-201-689-8562
China Domestic: 86 400 120 2840
Hong Kong: 800 965 561
Conference ID: 13718229

Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volume.

The replay will be accessible through April 15, 2021, by dialing the following numbers:

United States: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 13718229

A webcast will be available on the Company’s investor relations website at www.nfh.com.cn and will be archived on the site shortly after the call has concluded. A presentation to accompany the call will also be available for download on the website.

About New Frontier Health Corporation
New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals in operation or under construction in all four tier 1 cities and selected tier 2 cities. Additional information may be found at www.nfh.com.cn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210331005399/en/

CONTACT

Investors

Harry Chang

Tel: +852-9822-1806

Email: harry@new-frontier.com

ICR, LLC

William Zima

Tel: +1-203-682-8200

Email: bill.zima@icrinc.com

Media

Wenjing Liu

Tel: +86-10-5927-7342

Email: liu.wenjing@ufh.com.cn

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携